Pruritus among patients with nondialysis-dependent chronic kidney disease is associated with hospitalization and death. Pruritus is common among patients with nondialysis-dependent chronic kidney ...

In a study of patients with non-dialysis CKD, pruritus was associated with poor health-related quality-of-life. One in 4 patients with non-dialysis chronic kidney disease (ND-CKD) experiences moderate ...

Please provide your email address to receive an email when new articles are posted on . More than half of patients had moderate to severe chronic kidney disease-associated pruritus during the study ...

WASHINGTON, DC — The intensity of itch experienced by patients on hemodialysis with uremic pruritus can be eased with 12 weeks of treatment with difelikefalin (Korsuva, Cara Therapeutics), results ...

Uremic pruritus is a debilitating symptom frequently encountered in individuals with chronic kidney disease (CKD), particularly those receiving haemodialysis. This condition, characterised by ...

Difelikefalin, an investigational intravenous (IV) drug for treating itch (pruritus) in patients with end-stage renal disease on hemodialysis, was safe and effective in two parallel pivotal trials in ...

In its early stages, kidney disease may not cause any symptoms or signs. However, as it progresses, it can cause symptoms such as itchy skin, pruritus, and a rash. Around 35.5 million adults in the ...